(561) 802-3060 info@mri-news.com
Type 2 Diabetes and Kidney Disease

Type 2 Diabetes and Kidney Disease


Do you have Type 2 Diabetes and moderate renal (kidney) disease?  Clinical study Clinical research study enrolling now!

Learn more about the latest clinical advances for Type 2 Diabetes and moderate renal (kidney) failure.


We are currently enrolling adult volunteers in a clinical research study to evaluate an investigational medication for individuals who have type 2 diabetes and who also have moderate renal (kidney) failure.

Qualified candidates must:
•  be men or women 20 years of age or older
•  have been diagnosed with Type 2 Diabetes
•  have moderate renal (kidney) failure

There is no cost to participate in this clinical research study. Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.

For more information, please call (561) 802-3060, ext. 8036 or go to:  Learn More

Type 2 Diabetes Clinical Trial Closing Enrollment Soon!

Type 2 Diabetes Clinical Trial Closing Enrollment Soon!

Type 2 Diabetes Clinical Trial Closing Enrollment Soon!
For more information, or to see if you qualify for this study, go to: http://mri-news.com/pioneer-4/

 


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.


 

FDA Approves Dexcom G5 for Insulin Dosing

Users of the Dexcom G5 Mobile Continuous Glucose Monitoring System (Dexcom G5) can now rely on the device to make diabetes treatment decisions using two finger pricks daily, not multiple ones, following the U.S. Food and Drug Administration’s (FDA) approval of expanded use of the device.

On Tuesday, the FDA granted the expanded indication. Users must still calibrate the device at least two times a day by testing a fingertip blood sample with a blood glucose meter.


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.